Ferdinando De Vita
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 163 publications
Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.
Journal: ESMO gastrointestinal oncology
Published: August 28, 2026
HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Barriers and Priorities for Immunotherapy Implementation in Advanced Gastric Cancer: Findings from a Two-Phase Qualitative Study.
Journal: Journal of gastrointestinal cancer
Published: January 31, 2026
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 04, 2025
Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selection.
Journal: The oncologist
Published: October 07, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 29, 2025
Diagnostic and therapeutic appropriateness in different stages of esophageal/GEJ cancers. The FICOG project.
Journal: Future oncology (London, England)
Published: September 09, 2025
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy.
Journal: ESMO open
Published: September 07, 2025
Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma.
Journal: Signal transduction and targeted therapy
Published: July 28, 2025
Diagnostic Accuracy of Contrast-Enhanced Ultrasound in Differentiating RCC from AML in Small Hyperechoic Renal Masses (≤ 3 cm): A Retrospective Single-Center Study.
Journal: Clinical genitourinary cancer
Published: June 26, 2025
Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 08, 2025
Last Updated: 09/26/2026